Hazlett Burt & Watson Inc. Purchases 165 Shares of CVS Health Corporation $CVS

Hazlett Burt & Watson Inc. grew its position in shares of CVS Health Corporation (NYSE:CVS) by 10.9% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 1,682 shares of the pharmacy operator’s stock after buying an additional 165 shares during the quarter. Hazlett Burt & Watson Inc.’s holdings in CVS Health were worth $117,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CVS. Bell Investment Advisors Inc grew its stake in CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 248 shares during the last quarter. Roxbury Financial LLC grew its stake in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares during the last quarter. ORG Partners LLC grew its stake in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares during the last quarter. Saudi Central Bank bought a new stake in CVS Health during the first quarter worth about $34,000. Finally, Livelsberger Financial Advisory bought a new stake in CVS Health during the second quarter worth about $35,000. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Up 0.8%

Shares of NYSE CVS opened at $78.50 on Tuesday. The company’s 50 day simple moving average is $72.63 and its 200 day simple moving average is $67.75. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $79.68. The firm has a market capitalization of $99.56 billion, a P/E ratio of 21.93, a P/E/G ratio of 0.86 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health’s revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is 74.30%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research report on Saturday, September 27th. Wells Fargo & Company upped their target price on shares of CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Sanford C. Bernstein upped their target price on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Jefferies Financial Group upped their target price on shares of CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, June 30th. Finally, Mizuho upped their target price on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $79.80.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the sale, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.22% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.